MAZE logo

Maze Therapeutics, Inc. (MAZE) Shareholders Equity

Annual Shareholders Equity:

$196.90M+$186.85M(+1858.46%)
December 31, 2024

Summary

  • As of today, MAZE annual stockholders equity is $196.90 million, with the most recent change of +$186.85 million (+1858.46%) on December 31, 2024.
  • During the last 3 years, MAZE annual shareholders equity has risen by +$95.46 million (+94.10%).
  • MAZE annual shareholders equity is now at all-time high.

Performance

MAZE Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEbalance sheet metrics

Quarterly Shareholders Equity:

$262.24M-$29.83M(-10.21%)
June 30, 2025

Summary

  • As of today, MAZE quarterly stockholders equity is $262.24 million, with the most recent change of -$29.83 million (-10.21%) on June 30, 2025.
  • Over the past year, MAZE quarterly shareholders equity has increased by +$524.61 million (+199.95%).
  • MAZE quarterly shareholders equity is now -10.21% below its all-time high of $292.07 million, reached on March 31, 2025.

Performance

MAZE Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEbalance sheet metrics

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

MAZE Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+1858.5%+199.9%
3Y3 Years+94.1%-
5Y5 Years+94.1%-

MAZE Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+1858.5%-10.2%+199.9%
5Y5-Yearat high+1858.5%-10.2%+199.9%
All-TimeAll-Timeat high+1858.5%-10.2%+199.9%

MAZE Shareholders Equity History

DateAnnualQuarterly
Jun 2025
-
$262.24M(-10.2%)
Mar 2025
-
$292.07M(+48.3%)
Dec 2024
$196.90M
$196.90M(+98.2%)
DateAnnualQuarterly
Sep 2024
-
$99.37M(+137.9%)
Jun 2024
-
-$262.37M(-2709.6%)
Dec 2023
$10.05M(-90.1%)
$10.05M
Dec 2022
$101.44M
-

FAQ

  • What is Maze Therapeutics, Inc. annual stockholders equity?
  • What is the all-time high annual shareholders equity for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. annual shareholders equity year-on-year change?
  • What is Maze Therapeutics, Inc. quarterly stockholders equity?
  • What is the all-time high quarterly shareholders equity for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. quarterly shareholders equity year-on-year change?

What is Maze Therapeutics, Inc. annual stockholders equity?

The current annual shareholders equity of MAZE is $196.90M

What is the all-time high annual shareholders equity for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high annual stockholders equity is $196.90M

What is Maze Therapeutics, Inc. annual shareholders equity year-on-year change?

Over the past year, MAZE annual stockholders equity has changed by +$186.85M (+1858.46%)

What is Maze Therapeutics, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of MAZE is $262.24M

What is the all-time high quarterly shareholders equity for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high quarterly stockholders equity is $292.07M

What is Maze Therapeutics, Inc. quarterly shareholders equity year-on-year change?

Over the past year, MAZE quarterly stockholders equity has changed by +$524.61M (+199.95%)
On this page